Investor Relations

OPKO Announces First Quarter 2013 Operating and Financial Highlights more »

OPKO Health To Acquire PROLOR Biotech more »

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company more »

OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology more »

Email Alert Subscription

Step 1 of 3: Select Options

You may automatically receive OPKO Health, Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here.

Press Releases
SEC Filings
  
  
  
Stock Information
Send me a stock update at the end of the trading day.
Send me a stock update at the end of the week.
Alert me when the stock crosses the following price thresholds:
Current Stock Price is $6.940
    
Alert me when the stock changes more than % in one day.

Unsubscribe from Investor Relations email alerts.

Our email alerts provide automated opt-out methods as well as complete contact information.